Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):e88–e93. doi: 10.1097/QAI.0000000000000309

Table 2.

Time Interval Analysis

AFB (N=101)
Xpert (N=327)
P-value
N Median (IQR) N Median (IQR)
All participants
    Specimen transport to lab 76 0.2 (0.2 – 0.4) 306 0.3 (0.2 – 0.9) 0.26
    Laboratory processing 83 0.2 (0.2 – 0.3) 327 1.6 (1.3 – 2.6) < 0.001
    Result transfer to clinic 95 2.2 (1.1 – 4.1) 172 3.9 (2.4 – 5.5) < 0.001
    Total diagnostic time* 90 3.3 (2.1 – 5.2) 156 6.4 (5.3 – 8.1) < 0.001
Laboratory-confirmed pulmonary TB
    Specimen transport to lab 19 0.2 (0.2 – 0.4) 117 0.3 (0.2 – 0.9) 0.33
    Laboratory processing 20 0.3 (0.2 – 0.5) 124 1.6 (1.4 – 2.1) < 0.001
    Result transfer to clinic 26 2.0 (1.2 – 3.7) 82 3.9 (2.6 – 5.6) 0.03
    Total diagnostic time* 26 2.4 (2.1 – 4.0) 77 6.3 (5.2 – 8.2) <0.001
Sensitivity Analyses
    Total diagnostic time* (All time intervals) 72 3.3 (1.4 – 5.2) 156 6.4 (5.3 – 8.1) <0.001
    Total diagnostic time* (Same day AFB/Xpert) 56 3.2 (1.9 – 4.6) 74 6.3 (5.2 – 7.2) <0.001
*

Total diagnostic time was only calculated for participants who had data on the time of sputum specimen collection and the time a clinician received a test result.